Key Documents
Lawrence Tim Goodnough
Academic Appointments
- Professor - Med Center Line, Pathology
Contact Information
-
Clinical Offices
Pathology Department 300 Pasteur Dr H1402 MC 5626 Stanford, CA 94305 Tel Work (650) 723-5848 Fax (650) 723-9178Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
Professional Snapshot
Clinical Focus
- Pathology
Administrative Appointments
- Director, Transfusion Service Stanford Medical Center (2004 - present)
- Associate Director, Stanford Blood Center (2004 - present)
- Chair, School of Medicine Faculty Senate (2008 - 2010)
- Chair, School of Medicine Faculty Senate Steering Committee (2008 - present)
- Member, Committee on Performance, Professionalism, and Promotion Stanford University School of Medicine (2007 - present) View All 6administrative appointments of Lawrence Goodnough
Professional Education
| Board Certification: | Blood Bank, American Board of Pathology (1987) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (1981) |
| Medical Education: | University of Pennsylvania, PA (1975) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1978) |
| Fellowship: | University Hospital of Cleveland, OH (1981) |
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Amgen , Bjc healthcare services , Cls behring , Luitpold corp , Nework for the advancement of transfusion alternatives , Ortho biotech , Watson pharma |
Scientific Focus
Research Interests
Dr. Goodnough has a long-standing interest in alternatives to blood therapy. This includes the concept of antologous blood predonation before elective surgery; acute normovolemic hermodicution;erythropoietic agents to stimulate red blood cell production; pharmacologic strategies to reduce blood loss; artificial oxygen carriers; and re-evaluation of the transfusion trigger. Publications: Goodnough LT: "Erythropoietin", In Scientific Basis of Transfusion Medicine (Anderson K and Ness P),WB Saunders Co, Phila. 1994;830-842. Lenes B, Goodnough LT: Educational aspects of transfusion medicine, In Quality Assurance in Transfusion Medicine: Conceptual, Serologic, and Microbiologic Aspects. (Rock G, Seghatchin MJ, eds.), CRC Press, Boca Raton, FCA, 1992;Ch 5:89-103. Goodnough LT, Geha AS: A new era in blood conservation (editorial). Ann Thor Surg 1991;51:703-704.99.
Publications
- Implementation of a two-specimen requirement for verification of ABO/Rh for blood transfusion. Transfusion. 2009; (7): 1321-8
- A case of no pain and no gain from blood? Crit Care Med. 2009; (6): 2104-5
- Improving platelet supply chains through collaborations between blood centers and transfusion services. Transfusion. 2009; (10): 2040-7
- Why an alternative to blood transfusion? Crit Care Clin. 2009; (2): 261-77, Table of Contents
- Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion. 2009
Help